Knowing a tumor's molecular type enables neurosurgeons to make decisions such as how much brain tissue to remove and whether to place tumor-killing drugs directly into the brain - while the patient is still on the operating table.
The study by researchers at New York University, Columbia Engineering, and the New York Genome Center, combines a deep learning model with CRISPR screens to control the expression of human genes in different ways - such as flicking a light switch to shut them off completely or by using a dimmer knob to partially turn down their activity.
NHS technology provider C2-Ai has been recognised at four high-profile UK healthcare and technology awards on a single night, after surgical teams across dozens of hospitals delivered significant impact for patients on waiting lists.
Surgeons say they are revolutionising how NHS waiting lists are managed with the help of the UK company’s technology, which is providing staff with an unprecedented understanding of the risks facing every individual patient.
The largest ever single Better Meds project to date will bring Catalan Health Service's (CatSalut) ambition for providing integrated care via a patient and data-centric longitudinal electronic health record one step closer as it establishes its vendor-neutral health data platform and medication management system, which will eventually be available across the whole of Catalonia.
The Sussex Pathology Network has chosen Clinisys for a laboratory information system (LIMS) that will help its labs to collaborate, building on the supportive relationship that developed during the COVID-19 pandemic.
A single, hosted instance of WinPath Enterprise will replace the existing four live LIMS systems in use at the three trusts and seven laboratories within the network, of which two are at the end of their life.